Skip to main content
. 2017 May 12;8(30):50061–50070. doi: 10.18632/oncotarget.17833

Figure 3. The association of rs3025039 polymorphism with RCC susceptibility in the CC+CT vs. TT model.

Figure 3

(A) ORs and 95%CIs. (B) Sensitivity analysis. (C) Publication bias.